The Europe IV Equipment Market size is valued at USD 3.39 billion in 2023 and is predicted to grow at a CAGR of 5.5%, reaching USD 4.43 billion by 2028 during the forecast period 2023 to 2028.
Blood transfusions have grown increasingly prevalent in the medical and healthcare markets, owing to an increase in the number of disorders that cause blood loss. Because intravenous therapies are so important in blood transfusion procedures, the demand for IV equipment in the Europe market is expected to soar to new heights. One of the primary factors driving the growth of the Europe intravenous (IV) equipment market is the increasing prevalence of chronic diseases like cancer, kidney failure, and heart disease among the population.
Other indirect intravenous (IV) equipment market growth determinants include the emergence of ambulatory infusion pumps and the rise of numerous inventions and investigations in healthcare to integrate technology. In addition, growing government attempts to raise awareness, particularly in developing economies, and rising cases of lifestyle diseases like hypertension, diabetes, obesity, and depression, among others, will fuel lucrative intravenous (IV) equipment market expansion.
Furthermore, people with severe diseases and disorders frequently have difficulty swallowing food, pills, or liquids. In such instances, IV equipment aids in administering the proper pharmaceutical doses to the patients. Together with the increased frequency of malignancies, cardiovascular diseases, and tumors, this factor has resulted in a surge in demand for IV equipment in recent years.
An increase in the number of chronic diseases that require vascular access treatment. Over the last decades, the elderly population has increased dramatically. Furthermore, this expansion has occurred at an unprecedented rate in recent years. The people aged 65 and up were estimated to be 8.5 percent of the global population of 617 million people. In the next few years, such rapid growth in the geriatric population is expected to create lucrative growth potential for the IV equipment market. Because of this, the use of IV Equipment products to aid therapy and facilitate speedier recovery among the elderly is quite essential.
The treatment's high costs will operate as a market growth stumbling block. The market's growth rate will be further slowed by medication errors caused by infusion pumps, which will result in product recalls. In addition, unfavorable reimbursement policies, particularly in developing economies, would add to the intravenous (IV) equipment market's hurdles, as will strict regulatory requirements and compliances.
This research report on the Europe IV Equipment Market has been segmented and sub-segmented into the following categories:
By End User:
Geographically, the Europe IV Equipment Market has the largest share globally due to its advanced healthcare infrastructure and advanced technology and equipment usage.
The U.K IV Equipment Market is the largest in this region for infusion pumps since it has a well-developed medical infrastructure and a senior population that would require such therapy.
The German IV equipment market is expected to profit from rising needle stick injuries, a shift in demand toward ambulatory surgical centers and fusion pumps, and an increase in the number of surgical procedures conducted. As a result, central venous catheters (CVC) are the fastest-growing segment of vascular access devices in European countries.
KEY MARKET PLAYERS
Top Companies dominating the Europe IV Equipment Market are ICU Medical, Inc., Smiths Medical (U.K.), Moog, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG (Germany), Baxter International Inc., Fresenius SE & Co. KGaA (Germany), Terumo Corporation, C. R. Bard, Inc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com